Your browser doesn't support javascript.
loading
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Kwon, Joonha; Lee, Jun Hyeong; Lee, Young Han; Lee, Jeeyun; Ahn, Jin-Hee; Kim, Se Hyun; Kim, Seung Hyun; Kim, Tae Il; Yun, Kum-Hee; Park, Young Suk; Kim, Jeong Eun; Lee, Kyu Sang; Choi, Jung Kyoon; Kim, Hyo Song.
Affiliation
  • Kwon J; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
  • Lee JH; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
  • Lee YH; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim SH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim SH; Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Kim TI; Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Yun KH; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
  • Park YS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee KS; Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Choi JK; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
  • Kim HS; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Cancer Res Treat ; 54(4): 1240-1255, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35038826

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Treat Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Treat Year: 2022 Type: Article